Notice: This company has been marked as potentially delisted and may not be actively trading. Reneo Pharmaceuticals (RPHM) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Reneo Pharmaceuticals Short Interest DataReneo Pharmaceuticals (RPHM) has a short interest of 3.40 million shares, representing 15.65% of the float (the number of shares available for trading by the public). This marks a 5.26% increase in short interest from the previous month. The short interest ratio (days to cover) is 20.8, indicating that it would take 20.8 days of the average trading volume of 250,384 shares to cover all short positions.Current Short Interest3,400,000 sharesPrevious Short Interest3,230,000 sharesChange Vs. Previous Month+5.26%Dollar Volume Sold Short$4.45 millionShort Interest Ratio20.8 Days to CoverLast Record DateSeptember 15, 2024Outstanding Shares33,430,000 sharesFloat Size21,720,000 sharesShort Percent of Float15.65%Today's Trading Volume437,500 sharesAverage Trading Volume250,384 sharesToday's Volume Vs. Average175% Short Selling Reneo Pharmaceuticals? Sign up to receive the latest short interest report for Reneo Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRPHM Short Interest Over TimeRPHM Days to Cover Over TimeRPHM Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… Reneo Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/20243,400,000 shares $4.45 million +5.3%15.7%20.8 $1.31 8/31/20243,230,000 shares $4.78 million -0.9%14.9%26.2 $1.48 8/15/20243,260,000 shares $5.09 million +0.6%15.0%25.2 $1.56 7/31/20243,240,000 shares $4.83 million No Change14.9%12.6 $1.49 7/15/20243,240,000 shares $4.92 million -10.0%14.9%12.2 $1.52 6/30/20243,600,000 shares $5.44 million +0.6%16.6%13.4 $1.51 Get the Latest News and Ratings for RPHM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reneo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 6/15/20243,580,000 shares $5.94 million +2.3%16.5%14.9 $1.66 5/31/20243,500,000 shares $5.81 million -3.6%16.1%14.2 $1.66 5/15/20243,630,000 shares $5.81 million +18.2%16.7%13.7 $1.60 4/30/20243,070,000 shares $5.13 million +4.4%13.8%18.7 $1.67 4/15/20242,940,000 shares $4.88 million +0.7%13.2%13.8 $1.66 3/31/20242,920,000 shares $4.85 million +3.6%13.1%10.7 $1.66 3/15/20242,820,000 shares $4.68 million +8.9%12.7%5.6 $1.66 2/29/20242,590,000 shares $4.27 million +29.5%11.7%2.5 $1.65 2/15/20242,000,000 shares $3.34 million +22.7%9.0%1.9 $1.67 1/31/20241,630,000 shares $2.67 million +10.1%7.4%1.5 $1.64 1/15/20241,480,000 shares $2.49 million -15.4%6.7%1.4 $1.68 12/31/20231,750,000 shares $2.80 million -50.3%7.8%1.8 $1.60 12/15/20233,520,000 shares $5.00 million +30.9%15.6%4 $1.42 11/30/20232,690,000 shares $17.05 million +8.0%13.9%13.1 $6.34 11/15/20232,490,000 shares $16.46 million +5.5%12.8%15 $6.61 10/31/20232,360,000 shares $19.09 million +3.1%12.0%15.6 $8.09 10/15/20232,290,000 shares $16.97 million +12.3%11.6%14.9 $7.41 9/30/20232,040,000 shares $15.53 million -1.9%10.4%13.7 $7.62 9/15/20232,080,000 shares $15.25 million +2.5%10.6%14.7 $7.33 8/31/20232,030,000 shares $12.22 million +16.7%10.3%12.2 $6.02 8/15/20231,740,000 shares $9.81 million +18.4%8.9%11 $5.64 7/31/20231,470,000 shares $11.80 million +20.5%7.5%9.3 $8.03 7/15/20231,220,000 shares $8.98 million +36.9%6.2%7.4 $7.36 6/30/2023891,200 shares $5.85 million +83.1%6.0%5.5 $6.56 6/15/2023486,700 shares $3.49 million -12.3%3.3%3.4 $7.18 5/31/2023555,200 shares $4.44 million +117.2%5.1%5.4 $8.00 5/15/2023255,600 shares $2.10 million +121.1%2.3%2.4 $8.20 4/30/2023115,600 shares $1.18 million -9.2%1.2%1.3 $10.22 4/15/2023127,300 shares $865,640.00 -7.8%1.1%1.8 $6.80 3/31/2023138,100 shares $825,838.00 +19.5%1.2%2.4 $5.98 3/15/2023115,600 shares $502,860.00 +21.3%1.1%2.1 $4.35 2/28/202395,300 shares $289,712.00 +0.5%0.9%2 $3.04 2/15/202394,800 shares $265,440.00 +19.6%0.9%3 $2.80 1/31/202379,300 shares $214,903.00 -2.3%0.7%2.7 $2.71The #1 Coin for November 2024 (Ad)Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… 1/15/202381,200 shares $211,120.00 +59.2%0.7%3.1 $2.60 12/30/202251,000 shares $118,830.00 +6.9%0.5%2.3 $2.33 12/15/202247,700 shares $104,940.00 -24.3%0.4%2.6 $2.20 11/30/202263,000 shares $140,490.00 -7.2%0.6%3 $2.23 11/15/202267,900 shares $177,219.00 -3.1%0.6%3 $2.61 10/31/202270,100 shares $246,752.00 -7.6%0.7%2.6 $3.52 10/15/202275,900 shares $227,700.00 +14.0%0.7%1.6 $3.00 9/30/202266,600 shares $223,110.00 -14.5%0.6%1.4 $3.35 9/15/202277,900 shares $377,815.00 +8.7%0.7%1.1 $4.85 8/31/202271,700 shares $225,855.00 -2.2%0.7%0.9 $3.15 8/15/202273,300 shares $209,638.00 -35.0%0.7%0.8 $2.86 7/31/2022112,800 shares $398,184.00 -18.4%1.0%1.1 $3.53 7/15/2022138,300 shares $409,368.00 -26.0%1.3%1.4 $2.96 6/30/2022186,900 shares $495,285.00 -49.8%1.7%1.9 $2.65 6/15/2022372,600 shares $823,446.00 -4.4%3.4%4.1 $2.21 5/31/2022389,900 shares $807,093.00 +10.7%3.6%5.5 $2.07 5/15/2022352,300 shares $753,922.00 +5.2%3.2%5.3 $2.14 4/30/2022334,900 shares $776,968.00 +32.5%3.1%7.1 $2.32 4/15/2022252,800 shares $652,224.00 +2.7%2.3%5.8 $2.58 3/31/2022246,100 shares $723,534.00 +11.5%2.3%5.8 $2.94 3/15/2022220,800 shares $779,424.00 +6.7%2.0%4.8 $3.53 2/28/2022206,900 shares $997,258.00 +3.9%1.9%3.7 $4.82 2/15/2022199,200 shares $1.04 million +17.0%1.8%3.6 $5.21 1/31/2022170,300 shares $1.06 million -21.2%1.6%3 $6.21 1/15/2022216,000 shares $1.94 million -13.2%2.0%4.2 $8.98 12/31/2021248,900 shares $2.13 million -14.1%2.3%5.1 $8.55 12/15/2021289,800 shares $2.20 million +4.3%2.7%6 $7.58 11/30/2021277,800 shares $1.91 million -1.0%2.5%7.9 $6.88 11/15/2021280,600 shares $2.29 million -0.1%2.6%3.8 $8.17 10/29/2021280,900 shares $1.84 million -9.2%2.6%4 $6.56 10/15/2021309,200 shares $1.99 million -73.6%2.8%4.5 $6.44 9/30/20211,170,000 shares $8.72 million No Change10.6%17.2 $7.45 9/15/20211,170,000 shares $8.95 million +3.5%10.6%14.7 $7.65 8/31/20211,130,000 shares $12.51 million -1.7%10.3%12.3 $11.07 8/13/20211,150,000 shares $9.56 million No Change10.5%21.3 $8.31 RPHM Short Interest - Frequently Asked Questions What is Reneo Pharmaceuticals' current short interest? Short interest is the volume of Reneo Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of September 15th, traders have sold 3,400,000 shares of RPHM short. 15.65% of Reneo Pharmaceuticals' shares are currently sold short. Learn More on Reneo Pharmaceuticals' current short interest. What is a good short interest ratio for Reneo Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RPHM shares currently have a short interest ratio of 21.0. Learn More on Reneo Pharmaceuticals's short interest ratio. What is a good short interest percentage for Reneo Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 15.65% of Reneo Pharmaceuticals' floating shares are currently sold short. Is Reneo Pharmaceuticals' short interest increasing or decreasing? Reneo Pharmaceuticals saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 3,400,000 shares, an increase of 5.3% from the previous total of 3,230,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Reneo Pharmaceuticals' float size? Reneo Pharmaceuticals currently has issued a total of 33,430,000 shares. Some of Reneo Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Reneo Pharmaceuticals currently has a public float of 21,720,000 shares. How does Reneo Pharmaceuticals' short interest compare to its competitors? 15.65% of Reneo Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Reneo Pharmaceuticals: Fulcrum Therapeutics, Inc. (8.49%), Aurora Cannabis Inc. (8.05%), Lexeo Therapeutics, Inc. (9.24%), Tenaya Therapeutics, Inc. (21.42%), Fate Therapeutics, Inc. (9.97%), DiaMedica Therapeutics Inc. (0.35%), Atai Life Sciences (8.71%), Zentalis Pharmaceuticals, Inc. (6.55%), Acrivon Therapeutics, Inc. (5.07%), Molecular Partners AG (0.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($6.15 billion), Charter Communications, Inc. ($4.04 billion), Paychex, Inc. ($2.77 billion), Nu Holdings Ltd. ($2.71 billion), Cencora, Inc. ($2.34 billion), Aptiv PLC ($2.18 billion), Tractor Supply ($2.07 billion), International Paper ($2.01 billion), AppLovin Co. ($1.95 billion), and Moderna, Inc. ($1.89 billion). View all of the most shorted stocks. What does it mean to sell short Reneo Pharmaceuticals stock? Short selling RPHM is an investing strategy that aims to generate trading profit from Reneo Pharmaceuticals as its price is falling. RPHM shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Reneo Pharmaceuticals? A short squeeze for Reneo Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RPHM, which in turn drives the price of the stock up even further. How often is Reneo Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RPHM, twice per month. The most recent reporting period available is September, 15 2024. More Short Interest Resources from MarketBeat Related Companies Fulcrum Therapeutics Short Interest Data Aurora Cannabis Short Interest Data Lexeo Therapeutics Short Interest Data Tenaya Therapeutics Short Interest Data Fate Therapeutics Short Interest Data DiaMedica Therapeutics Short Interest Data Atai Life Sciences Short Interest Data Zentalis Pharmaceuticals Short Interest Data Acrivon Therapeutics Short Interest Data Molecular Partners Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RPHM) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reneo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reneo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
